This brand name is authorized in Albania, Austria, Germany, Estonia, Spain, Hong Kong, Croatia, Ireland, Italy, Lithuania, Malta, Netherlands, Poland, Romania, Singapore, United Kingdom, South Africa
The drug AIRFLUSAL contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Salmeterol
UNII 6EW8Q962A5 - SALMETEROL XINAFOATE
|
|
Salmeterol is a selective long-acting (12 hour) β2 adrenoceptor agonist. These pharmacological properties of salmeterol offer more effective protection against histamine-induced bronchoconstriction and produce a longer duration of bronchodilation, lasting for at least 12 hours, than recommended doses of conventional short-acting β2 agonists. |
|
2
Fluticasone
UNII O2GMZ0LF5W - FLUTICASONE PROPIONATE
|
|
Fluticasone has anti-inflammatory and vasoconstrictive features. Fluticasone given by inhalation at recommended doses has a potent glucocorticoid anti-inflammatory action within the lungs, resulting in a reduction of both symptoms and exacerbations of asthma, with a lower incidence and severity of adverse effects than those observed when corticosteroids are administered systemically. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| R03AK06 | Salmeterol and fluticasone | R Respiratory system → R03 Drugs for obstructive airway diseases → R03A Adrenergics, inhalants → R03AK Adrenergics and other drugs for obstructive airway diseases |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: AL | Fondi i Sigurimit të Detyrueshëm të Kujdesit Shëndetësor | Identifier(s): 515/237, 516/237 |
| Country: DE | Bundesinstitut für Arzneimittel und Medizinprodukte | Identifier(s): 09121840, 09121857, 09121863, 11889956, 11889962, 11889979, 11889985, 13896972, 13896989, 14238774, 16395302, 16582062, 16803623, 16803646, 16803652, 16884254 |
| Country: EE | Ravimiamet | Identifier(s): 1636466, 1636477, 1636488, 1636499, 1636501, 1636512, 1636523, 1636534, 1636545, 1636556 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 80248, 80249 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 309504, 342154, 342156, 377145, 377147, 377149 |
| Country: HK | Department of Health Drug Office | Identifier(s): 63960, 63961, 63964 |
| Country: IE | Health Products Regulatory Authority | Identifier(s): 16005, 16011, 53487, 53488 |
| Country: IT | Agenzia del Farmaco | Identifier(s): 043262029, 045152016, 045152081 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1072343, 1072344, 1074618, 1074619, 1074620, 1074621, 1074973, 1074974, 1074975, 1074976, 1079504, 1079505, 1082679, 1082680, 1082681, 1082682, 1082683, 1082684, 1082685, 1082686, 1082687, 1082688, 1082689, 1082690, 1082691, 1082692, 1082693, 1082694, 1082695, 1082696 |
| Country: MT | Medicines Authority | Identifier(s): AA1122/02401, AA1122/02402 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 127663, 62529, 62537 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100356030, 100356053, 100365224, 100365230, 100443473, 100447270 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W60522001, W60522002, W60522003, W60522004, W60522005, W60522006, W60522007, W61757001, W61757002, W61757003, W61757004, W61757005, W61757006, W61757007 |
| Country: SG | Health Sciences Authority | Identifier(s): 15523P |
| Country: ZA | Health Products Regulatory Authority | Identifier(s): 47/21.5.4/1320, 47/21.5.4/1321 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
